Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,714
  • Shares Outstanding, K 163,758
  • Annual Sales, $ 16,210 K
  • Annual Income, $ -8,210 K
  • 60-Month Beta 0.60
  • Price/Sales 0.42
  • Price/Cash Flow N/A
  • Price/Book 1.74
Trade CVSI with:
  • Price/Earnings ttm 3.90
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings $0.00 on 11/14/23
  • Latest Earnings Date 03/28/24 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0301 +36.21%
on 03/06/24
0.0435 -5.75%
on 03/28/24
+0.0070 (+20.59%)
since 02/28/24
3-Month
0.0301 +36.21%
on 03/06/24
0.0435 -5.75%
on 03/28/24
+0.0070 (+20.59%)
since 12/28/23
52-Week
0.0275 +49.09%
on 11/14/23
0.0600 -31.67%
on 09/15/23
-0.0021 (-4.87%)
since 03/28/23

Most Recent Stories

More News
CV Sciences, Inc. Launches Reserve Sleep Gummies

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV Sciences, Inc. Reports First Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0410 (+5.13%)
CV Sciences, Inc. Introduces New THC Offering

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0410 (+5.13%)
CV Sciences, Inc. (CVSI) Reports Q3 Loss, Misses Revenue Estimates

CV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of 50% and 6.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CVSI : 0.0410 (+5.13%)
MEIP : 4.00 (+2.04%)
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol...

CVSI : 0.0410 (+5.13%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Key Turning Points

3rd Resistance Point 0.0524
2nd Resistance Point 0.0479
1st Resistance Point 0.0445
Last Price 0.0410
1st Support Level 0.0366
2nd Support Level 0.0321
3rd Support Level 0.0287

See More

52-Week High 0.0600
Fibonacci 61.8% 0.0476
Fibonacci 50% 0.0437
Last Price 0.0410
Fibonacci 38.2% 0.0399
52-Week Low 0.0275

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar